CVS Health Corporation (TSX:CVS)
21.28
-0.11 (-0.51%)
Nov 13, 2026, 4:00 PM EST
CVS Health Revenue
CVS Health had revenue of $108.40B USD in the quarter ending September 30, 2026, with 5.37% growth. This brings the company's total for the last twelve months to $420.61B, up 6.73% year-over-year. In the year 2025, CVS Health had annual revenue of $402.07B with 7.85% growth.
Revenue (ttm)
$420.61B
Revenue Growth
+6.73%
P/S Ratio
0.27
Revenue / Employee
$1.40M
Employees
300,000
Market Cap
162.93B CAD
Revenue by Segment
- Health Services 190.43B 40.2%
- Health Care Benefits 143.35B 30.3%
- Pharmacy & Consumer Wellness 139.37B 29.5%
Fiscal year ended Dec 31, 2025 See the full CVS Health breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 402.07B | 29.26B | 7.85% |
| Dec 31, 2024 | 372.81B | 15.03B | 4.20% |
| Dec 31, 2023 | 357.78B | 35.31B | 10.95% |
| Dec 31, 2022 | 322.47B | 30.36B | 10.39% |
| Dec 31, 2021 | 292.11B | 23.41B | 8.71% |
| Dec 31, 2020 | 268.71B | 11.93B | 4.65% |
| Dec 31, 2019 | 256.78B | 62.20B | 31.96% |
| Dec 31, 2018 | 194.58B | 9.79B | 5.30% |
| Dec 31, 2017 | 184.79B | 7.24B | 4.08% |
| Dec 31, 2016 | 177.55B | 24.26B | 15.82% |
| Dec 31, 2015 | 153.29B | 13.92B | 9.99% |
| Dec 31, 2014 | 139.37B | 12.61B | 9.94% |
| Dec 31, 2013 | 126.76B | 3.64B | 2.96% |
| Dec 31, 2012 | 123.12B | 16.02B | 14.96% |
| Dec 31, 2011 | 107.10B | 11.32B | 11.82% |
| Dec 31, 2010 | 95.78B | -2.44B | -2.48% |
| Dec 31, 2009 | 98.22B | 10.74B | 12.28% |
| Dec 31, 2008 | 87.47B | 11.14B | 14.60% |
| Dec 29, 2007 | 76.33B | 32.51B | 74.18% |
| Dec 30, 2006 | 43.82B | 6.81B | 18.41% |
| Dec 31, 2005 | 37.01B | 6.41B | 20.96% |
| Jan 1, 2005 | 30.59B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Apotex Health | 3.21B |
| Extendicare | 2.17B |
| Curaleaf Holdings | 1.92B |
| Green Thumb Industries | 1.76B |
| WELL Health Technologies | 1.56B |
| Sienna Senior Living | 1.11B |
| Vireo Growth | 611.54M |
| Knight Therapeutics | 563.45M |
CVS Health News
- 19 hours ago - CVS says GLP-1s save money when priced below $350 per month - New York Post
- 22 hours ago - CVS Health releases new data on GLP-1 benefits, affordability challenges - TheFly
- 22 hours ago - CVS Health study highlights GLP-1 benefits and the affordability challenge - PRNewsWire
- 3 days ago - CVS spin off won’t satisfy lawmakers, may help investors in long run, WSJ says - TheFly
- 3 days ago - CVS Breakup Won't Satisfy Washington. It Could Still Work for Wall Street. - WSJ
- 3 days ago - Did CVS Health Corporation Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
- 3 days ago - CVS Pharmacy® launches latest collection of Caliber® Artist Series colleague-designed journals - PRNewsWire
- 4 days ago - CVS Health price target lowered to $112 from $123 at Wells Fargo - TheFly